Tiotropium as a Part of Complex Therapy in Patients with Chronic Obstructive Pulmonary Disease and Newly Diagnosed Pulmonary Tuberculosis
At the present time the number of patients with combination of chronic obstructive pulmonary disease and pulmonary tuberculosis is growing. The study was aimed to assess the efficacy of complex therapy including long-acting anticholinergic drug in patients with pulmonary tuberculosis and chronic obstructive pulmonary disease. The study showed that tiotropium as a part of complex therapy significantly reduced clinical manifestations, decreased the severity of bronchial obstructive syndrome and improved compliance to long-term antituberculous therapy. By the end of the 4th month of therapy comparison groups had significant differences in smear negativity, abacillation and closure of necrotic cavities.